We are live on
!
Find out more
BCM
Bronte Capital Management Portfolio holdings
AUM
$931M
1-Year Est. Return
47.97%
This Fund
S&P 500
This Quarter
Est. Return
+8.4%
1 Year Est. Return
+47.97%
3 Year Est. Return
+122.73%
5 Year Est. Return
+132.88%
10 Year Est. Return
–
AUM
$931M
AUM Growth
-$78.8M
(-7.8%)
Cap. Flow
-$108M
Cap. Flow
% of AUM
-11.56%
Top 10 Holdings %
Top 10 Hldgs %
71.82%
Holding
69
New
15
Increased
8
Reduced
33
Closed
12
Avg Time Held Equity + Options
7.5
quarters
Top 10 Avg Time Held Equity + Options
13.7
quarters
Top 20 Avg Time Held Equity + Options
11.1
quarters
Avg Time Held Equity only
7.6
quarters
Top 10 Avg Time Held Equity only
13.7
quarters
Top 20 Avg Time Held Equity only
12.7
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$17.8M |
| 2 |
Brown-Forman Class B
BF.B
|
+$12.5M |
| 3 |
iShares Core S&P Small-Cap ETF
IJR
|
+$3.16M |
| 4 |
Revolution Medicines
RVMD
|
+$2.74M |
| 5 |
Tyler Technologies
TYL
|
+$2.62M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Interactive Brokers
IBKR
|
+$33.1M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$27.5M |
| 3 |
iShares Russell 2000 Growth ETF
IWO
|
+$11.8M |
| 4 |
Herbalife
HLF
|
+$8.5M |
| 5 |
Pinterest
PINS
|
+$7.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 23.01% |
| 2 | Miscellaneous | 17.74% |
| 3 | Communication Services | 15.44% |
| 4 | Healthcare | 13.95% |
| 5 | Consumer Staples | 10.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Alphabet (Google) Class A
GOOGL
$4.29T
| $109M | 11.71% |
305,165
-76,325
| -20% | -$27.5M |
2018 Q4
30 quarters
|
|
2
Regeneron Pharmaceuticals
REGN
$76.4B
| $101M | 10.89% |
162,618
-10,169
| -6% | -$6.92M |
2020 Q4
22 quarters
|
|
|
3
Interactive Brokers
IBKR
$39.8B
| $76.9M | 8.26% |
883,526
-398,205
| -31% | -$33.1M |
2018 Q4
30 quarters
|
|
4
Berkshire Hathaway Class B
BRK.B
$1.08T
| $73M | 7.84% |
145,847
-9,216
| -6% | -$4.43M |
2018 Q4
30 quarters
|
|
5
Amazon
AMZN
$2.8T
| $62.3M | 6.69% |
261,433
-24,306
| -9% | -$6.1M |
2023 Q1
13 quarters
|
|
6
Philip Morris
PM
$300B
| $54.3M | 5.83% |
300,176
-40,922
| -12% | -$7.1M |
2021 Q3
19 quarters
|
|
|
7
CALL
Regeneron Pharmaceuticals
REGN
$76.4B
| $42.8M | 4.59% |
68,600
| – | – |
2025 Q4
2 quarters
|
|
8
Corteva
CTVA
$9.64B
| $38.7M | 4.15% |
456,656
-46,134
| -9% | -$3.7M |
2019 Q3
27 quarters
|
|
9
Capital One
COF
$120B
| $34.8M | 3.74% |
173,523
-13,846
| -7% | -$2.65M |
2025 Q2
4 quarters
|
|
|
10
Walt Disney
DIS
$181B
| $34.7M | 3.72% |
360,243
+174,566
| +94% | +$17.8M |
2026 Q1
1 quarter
|
|
11
First Citizens BancShares
FCNCA
$23.4B
| $29.5M | 3.17% |
14,179
-2,313
| -14% | -$4.64M |
2023 Q1
13 quarters
|
|
12
BBB Foods
TBBB
$6.39B
| $22.2M | 2.39% |
533,151
+45,601
| +9% | +$1.74M |
2025 Q4
2 quarters
|
|
13
Aurora
AUR
$11.5B
| $14.9M | 1.6% |
2,186,821
-131,927
| -6% | -$807K |
2026 Q1
1 quarter
|
|
14
Nektar Therapeutics
NKTR
$1.37B
| $13.9M | 1.49% |
198,434
+178
| +0.1% | +$13K |
2026 Q1
1 quarter
|
|
15
Graham Holdings Company
GHC
$4.95B
| $13.1M | 1.4% |
11,454
-1,331
| -10% | -$1.5M |
2020 Q3
23 quarters
|
|
16
iShares Biotechnology ETF
IBB
$10.7B
| $12.5M | 1.34% |
65,807
-3,458
| -5% | -$594K |
2022 Q2
16 quarters
|
|
|
17
Brown-Forman Class B
BF.B
$11.9B
| $12.4M | 1.33% |
+464,313
| New | +$12.5M |
2026 Q2
0 quarters
|
|
18
Alnylam Pharmaceuticals
ALNY
$30B
| $10.7M | 1.14% |
35,384
-1,861
| -5% | -$561K |
2025 Q3
3 quarters
|
|
19
Sociedad Química y Minera de Chile
SQM
$18.5B
| $8.61M | 0.92% |
116,308
-6,111
| -5% | -$512K |
2021 Q4
18 quarters
|
|
20
Global E Online
GLBE
$6.54B
| $7.91M | 0.85% |
227,644
+14,542
| +7% | +$460K |
2026 Q1
1 quarter
|
|
21
Newmont
NEM
$120B
| $6.49M | 0.7% |
69,494
-5,914
| -8% | -$644K |
2025 Q2
4 quarters
|
|
|
B
22
Barrick Mining
B
$64.5B
| $5.38M | 0.58% |
146,359
-12,382
| -8% | -$508K |
2025 Q2
4 quarters
|
|
23
LiveRamp
RAMP
$2.29B
| $4.83M | 0.52% |
128,348
-94,867
| -43% | -$3.12M |
2023 Q4
10 quarters
|
|
|
24
Herbalife
HLF
$1.33B
| $4.25M | 0.46% |
323,386
-616,540
| -66% | -$8.5M |
2018 Q4
30 quarters
|
|
|
25
Revolution Medicines
RVMD
$43.1B
| $3.52M | 0.38% |
+18,780
| New | +$2.74M |
2026 Q2
0 quarters
|
|
Similar funds
AG
ACM
SAM
NS
PA
ACM
CICI
CAM
Bronte Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Bronte Capital Management held 69 positions worth $931M, down 7.8% from $1.01B the previous quarter. Its ten largest holdings account for 72% of the portfolio.
Bronte Capital Management withdrew a net $108M in Q2 2026, closing 12 positions and reducing 33 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $11.8M position sold in full.
By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 23% a quarter earlier, followed by Miscellaneous and Communication Services.
Against the trend, Bronte Capital Management opened a new position in Brown-Forman Class B worth $12.4M.
- Bronte Capital Management's largest Q2 2026 buy was Brown-Forman Class B: 464,313 shares worth $12.4M.
- Bronte Capital Management added most to Walt Disney in Q2 2026, an estimated $17.8M increase.
- Bronte Capital Management's biggest Q2 2026 reduction was Interactive Brokers, cutting an estimated $33.1M.
- Bronte Capital Management fully exited iShares Russell 2000 Growth ETF in Q2 2026, selling an estimated $11.8M.
- Bronte Capital Management's ten largest holdings make up 72% of its $931M portfolio in Q2 2026.
- Bronte Capital Management opened 15 new positions and closed 12 in Q2 2026.
- Bronte Capital Management's portfolio value fell 7.8% quarter-over-quarter to $931M.
Based on Bronte Capital Management's 13F filing for Q2 2026, filed 5 Aug 2026.